China Respiratory Device Market

China Respiratory Device Market Size, Share & Trends Analysis Report by Product (Therapeutic Devices, Diagnostic and Monitoring Devices, and Consumables and Accessories), by End-User (Homecare and Hospitals and Clinics) and Forecast 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2022 | Report Code: OMR2020705 | Category : Medical Devices | Delivery Format: /

The China respiratory device market was valued at around $2.0 billion in 2018 and is estimated to grow at a CAGR of around 7.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in the country. A high level of air pollution and a significant number of smokers in China is boosting the demand for respiratory devices in the country. From June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. About 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had the problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.

The China respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the country’s market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care. 

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include BMC Medical Co., Ltd., ResMed Corp., Cipla Ltd., GlaxoSmithKline PLC, 3M Co., Novartis AG, Omron Healthcare Inc., and others. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. 

Research Methodology

The market study of the China respiratory device market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for respiratory device manufacturers, contract research organizations (CROs), the healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

  1. China Respiratory Device Market Research and Analysis by Product
  2. China Respiratory Device Market Research and Analysis by End-User

The Report covers:

  • Comprehensive research methodology of the China respiratory device market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the China respiratory device market.
  • Insights about market determinants which are stimulating the China respiratory device market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report 

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. China Respiratory Device Market by Product 

5.1.1. Therapeutic Devices

5.1.2. Diagnostic and Monitoring Devices

5.1.3. Consumables and Accessories

5.2. China Respiratory Device Market by End-User

5.2.1. Homecare

5.2.2. Hospitals and Clinics

6. Regional Analysis

6.1. China

6.2. Japan

6.3. India

6.4. Rest of China

7. Company Profiles

7.1. 3M Co.

7.2. Acorda Therapeutics, Inc.

7.3. Adamis Pharmaceuticals Corp.

7.4. Adherium Ltd.

7.5. Aradigm Corp.

7.6. AstraZeneca PLC

7.7. Beximo Pharmaceuticals Ltd.

7.8. BMC Medical Co., Ltd.

7.9. Boehringer Ingelheim International GmbH 

7.10. Cipla Ltd.

7.11. GlaxoSmithKline PLC

7.12. Koninklijke Philips N.V.

7.13. MidasCare Pharmaceutical Pvt. Ltd.

7.14. Mylan N.V.

7.15. Novartis AG

7.16. Omron Healthcare Inc.

7.17. ResMed Corp.

7.18. Sunovion Pharmaceuticals

7.19. Teijin Pharma Ltd.

7.20. Teva Pharmaceuticals Industries Ltd.

1. CHINA RESPIRATORY DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

2. CHINA RESPIRATORY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

1. CHINA RESPIRATORY DEVICE MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

2. CHINA RESPIRATORY DEVICE MARKET SHARE BY END-USER, 2018 VS 2025 (%)